Sign In
Buy AXS
$95.44
-0.460 (-0.480%)
At Close: Jun 02, 2026
Axis Capital (AXS) Q2 Earnings Surpass Estimates
06:46pm, Tuesday, 29'th Jul 2025
Axis Capital (AXS) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $2.93 per share a year ago.
PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or "the Company") (NYSE: AXS) today announced financial results for the second quarter e
Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy
01:46pm, Friday, 25'th Jul 2025
Axsome's valuation is driven by its promising pipeline, with Auvelity as a proven commercial success and Symbravo and AXS-12 showing solid potential. Recent setbacks include the FDA's refusal to file
Earnings Preview: Axis Capital (AXS) Q2 Earnings Expected to Decline
11:00am, Tuesday, 22'nd Jul 2025
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Axis Capital (AXS) is Poised to Beat Earnings Estimates Again
01:11pm, Wednesday, 09'th Jul 2025
Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AXIS Capital to Release Second Quarter Financial Results on July 29, 2025
04:15pm, Tuesday, 01'st Jul 2025
PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results
AXS Outperforms Industry, Trades at a Discount: How to Play the Stock
12:51pm, Tuesday, 17'th Jun 2025
AXIS Capital gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.
Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025
07:00am, Wednesday, 11'th Jun 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today an
AXIS Capital And 7% Yield From Its Preferred Stock
01:14pm, Wednesday, 04'th Jun 2025
AXS.PR.E preferred shares are undervalued, offering a 6.85% yield and trading at a wider spread than similar investment-grade peers. AXIS Capital Holdings Limited maintains strong credit ratings (A+/A
Axis Capital (AXS) is a Top-Ranked Value Stock: Should You Buy?
10:46am, Wednesday, 04'th Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Axis Capital (AXS) Up 5.3% Since Last Earnings Report?
12:36pm, Friday, 30'th May 2025
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
AXS vs. ACGL: Which P&C Insurance Stock Should You Hold Now?
10:51am, Thursday, 29'th May 2025
Let's see how AXS and ACGL fare in terms of some of the key metrics.
Here's Why Axis Capital (AXS) is a Strong Value Stock
10:46am, Monday, 19'th May 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AXIS Capital Declares Quarterly Dividends
04:15pm, Thursday, 15'th May 2025
PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited ("AXIS Capital" or the “Company”) (NYSE: AXS) today announced that its Board of Directors has declared a quart
Here's Why Axis Capital (AXS) is a Strong Momentum Stock
10:56am, Thursday, 15'th May 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
